Duchnowski Piotr, Śmigielski Witold, Kołsut Piotr
Cardinal Wyszynski National Institute of Cardiology, 04-628 Warsaw, Poland.
J Clin Med. 2025 Apr 15;14(8):2719. doi: 10.3390/jcm14082719.
Prolonged use of inotropes drugs in the early postoperative period is one of the most common complications occurring in patients undergoing heart valve surgery. Patients requiring prolonged support via inotropes drugs are significantly more likely to experience serious postoperative complications such as acute kidney injury, cardiogenic shock, multiple organ dysfunction syndrome, and death. This study assessed the usefulness of selected perioperative parameters in predicting prolonged postoperative use of inotropic drugs and cardiogenic shock and/or death in a group of patients requiring prolonged supply of inotropes drugs. This prospective study was conducted on a group of 607 patients undergoing heart valve surgery. The primary endpoint in-hospital follow-up was prolonged postoperative use of inotropes drugs. The secondary composite endpoint was cardiogenic shock requiring mechanical circulatory support (MCS) and/or death from any cause in patients with prolonged postoperative use of inotropes drugs. A total of 210 patients required inotropes drugs for more than 48 h. Age ( = 0.03), preoperative atrial fibrillation ( < 0.001), preoperative NT-proBNP level ( < 0.001), Troponin T measured one day after surgery (TnT II) ( < 0.001), and the need for urgent postoperative rethoracotomy ( < 0.001) remained independent predictors of primary endpoint. Preoperative hemoglobin level ( = 0.001) and TnT II ( < 0.001) were independent predictors of death and cardiogenic shock requiring MCS. Patients with elevated preoperative NT-proBNP values, as well as with increasing postoperative troponin T levels, are at risk of prolonged postoperative use of inotropes drugs, a complication which is associated with a significant risk of developing further adverse consequences, such as cardiogenic shock and death.
术后早期长期使用强心药物是心脏瓣膜手术患者最常见的并发症之一。需要通过强心药物进行长期支持的患者更有可能出现严重的术后并发症,如急性肾损伤、心源性休克、多器官功能障碍综合征和死亡。本研究评估了一组需要长期供应强心药物的患者中,选定的围手术期参数在预测术后长期使用强心药物以及心源性休克和/或死亡方面的有用性。这项前瞻性研究是对一组607例接受心脏瓣膜手术的患者进行的。住院随访的主要终点是术后长期使用强心药物。次要复合终点是术后长期使用强心药物的患者中需要机械循环支持(MCS)的心源性休克和/或任何原因导致的死亡。共有210例患者需要使用强心药物超过48小时。年龄(=0.03)、术前心房颤动(<0.001)、术前NT-proBNP水平(<0.001)、术后一天测得的肌钙蛋白T(TnT II)(<0.001)以及术后紧急开胸手术的需求(<0.001)仍然是主要终点的独立预测因素。术前血红蛋白水平(=0.001)和TnT II(<0.001)是需要MCS的心源性休克和死亡的独立预测因素。术前NT-proBNP值升高以及术后肌钙蛋白T水平升高的患者有术后长期使用强心药物的风险,这种并发症与发生进一步不良后果(如心源性休克和死亡)的重大风险相关。